ODDIFACT is a ‘techdev’ startup specializing in the repositioning of biosimilar drugs into fast-go-to patients rare diseases treatments.
Thanks to an AI backbone, ODDIFACT develops and sells projects of new treatments to pharmaceutical companies through M&A and License-Out deals.
This internship offers a unique opportunity to gain in-depth knowledge of the pharmaceutical laboratory sector, the biosimilars market, and M&A / License Out operations.